S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy

Nutrition Research

Volumn 34, Issue 2, 2014, Pages 116-125

  Virk Baker, Mandeep K ^a   Barnes, Stephen ^b,c   Krontiras, Helen ^c,d   Nagy, Tim R ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Kentucky   (United States)

Author keywords

Breast biopsy; Breast cancer; Dietary soy isoflavones; Ductal hyperplasia; Postmenopausal women; S ( )equol status

Indexed keywords

DAIDZEIN; EQUOL; ISOFLAVONE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CANCER RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EXPOSURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SPECTROMETRY; MULTIPLE REACTION ION MONITORING MASS SPECTROMETRY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SOYBEAN; UNITED STATES; URINALYSIS;

AA; AFRICAN AMERICAN; AS; ASIAN AMERICAN; BMI; BODY MASS INDEX; BREAST BIOPSY; BREAST CANCER; CI; CONFIDENCE INTERVAL; DIETARY SOY ISOFLAVONES; DUCTAL HYPERPLASIA; ER; ER+; ER-; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR NEGATIVE; ESTROGEN RECEPTOR POSITIVE; FFQ; FOOD FREQUENCY QUESTIONNAIRE; LC-MRM-MS; LIQUID CHROMATOGRAPHY-MULTIPLE REACTION ION MONITORING MASS SPECTROMETRY; ODDS RATIO; OR; POSTMENOPAUSAL WOMEN; S-(-)EQUOL STATUS; SOY SCREEN QUESTIONNAIRE; SSQ; UAB; UNIVERSITY OF ALABAMA AT BIRMINGHAM.;

AGED; BIOLOGICAL AVAILABILITY; BIOPSY; BREAST; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; EQUOL; ESTROGEN RECEPTOR BETA; FEMALE; FOOD HABITS; HUMANS; ISOFLAVONES; MIDDLE AGED; ODDS RATIO; PHYTOESTROGENS; POSTMENOPAUSE; SOY FOODS; SOYBEANS; UNITED STATES;

EID: 84892879057     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2013.12.002     Document Type: Article

References (68)

1. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997, 350:990-994.
2. Wu A.H., Wan P., Hankin J., Tseng C.C., Yu M.C., Pike M.C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002, 23:1491-1496.
3. Wu A.H., Yu M.C., Tseng C.C., Twaddle N.C., Doerge D.R. Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 2004, 25:77-81.
4. Dai Q., Shu X.O., Jin F., Potter J.D., Kushi L.H., Teas J., et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001, 85:372-378.
5. Dong J.Y., Qin L.Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011, 125:315-323.
6. Wu A.H., Ziegler R.G., Horn-Ross P.L., Nomura A.M., West D.W., Kolonel L.N., et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996, 5:901-906.
7. Yamamoto S., Sobue T., Kobayashi M., Sasaki S., Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst 2003, 95:906-913.
8. den T.I., Keinan-Boker L., Veer P.V., Arts C.J., Adlercreutz H., Thijssen J.H., et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:223-228.
9. Horn-Ross P.L., John E.M., Lee M., Stewart S.L., Koo J., Sakoda L.C., et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001, 154:434-441.
10. Keinan-Boker L., van der Schouw Y.T., Grobbee D.E., Peeters P.H. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 2004, 79:282-288.
11. Linseisen J., Piller R., Hermann S., Chang-Claude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2004, 110:284-290.
12. Piller R., Chang-Claude J., Linseisen J. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 2006, 15:225-232.
13. Horn-Ross P.L., Hoggatt K.J., West D.W., Krone M.R., Stewart S.L., Anton H., et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002, 13:407-415.
14. Korde L.A., Wu A.H., Fears T., Nomura A.M., West D.W., Kolonel L.N., et al. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev 2009, 18:1050-1059.
15. Messina M., Nagata C., Wu A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006, 55:1-12.
16. Messina M., Hilakivi-Clarke L. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer 2009, 61:792-798.
17. Shu X.O., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001, 10:483-488.
18. Thanos J., Cotterchio M., Boucher B.A., Kreiger N., Thompson L.U. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006, 17:1253-1261.
19. Knight D.C., Eden J.A. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996, 87:897-904.
20. Limer J.L., Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004, 6:119-127.
21. Barnes S., Prasain J., D'Alessandro T., Arabshahi A., Botting N., Lila M.A., et al. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct 2011, 2:235-244.
22. Bowey E., Adlercreutz H., Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003, 41:631-636.
23. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998, 68:1333S-1346S.
24. Yuan J.M., Wang Q.S., Ross R.K., Henderson B.E., Yu M.C. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 1995, 71:1353-1358.
25. Zubik L., Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 2003, 77:1459-1465.
26. Muthyala R.S., Ju Y.H., Sheng S., Williams L.D., Doerge D.R., Katzenellenbogen B.S., et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004, 12:1559-1567.
27. Setchell K.D., Clerici C., Lephart E.D., Cole S.J., Heenan C., Castellani D., et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 2005, 81:1072-1079.
28. Shinkaruk S., Carreau C., Flouriot G., Bennetau-Pelissero C., Potier M. Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity. Nutrients 2010, 2:340-354.
29. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H., et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 2000, 10:127-135.
30. Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005, 230:155-170.
31. Hutchins A.M., Slavin J.L., Lampe J.W. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J Am Diet Assoc 1995, 95:545-551.
32. Kelly G.E., Joannou G.E., Reeder A.Y., Nelson C., Waring M.A. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995, 208:40-43.
33. Lampe J.W., Karr S.C., Hutchins A.M., Slavin J.L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998, 217:335-339.
34. Rowland I.R., Wiseman H., Sanders T.A., Adlercreutz H., Bowey E.A. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 2000, 36:27-32.
35. Liu B., Liu A., Uchiyama S., Ueno T., Li X., Wang P. Prevalence of equol producer phenotype and its relations to lifestyle factors and dietary intakes among lifestyle factors and dietary intakes among healthy Chinese adults in Beijing. Wei Sheng Yan Jiu 2010, 39:59-64.
36. Song K.B., Atkinson C., Frankenfeld C.L., Jokela T., Wahala K., Thomas W.K., et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 2006, 136:1347-1351.
37. Axelson M., Setchell K.D. The excretion of lignans in rats-evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 1981, 123:337-342.
38. Fortina M.G., Ricci G., Foschino R., Picozzi C., Dolci P., Zeppa G., et al. Phenotypic typing, technological properties and safety aspects of Lactococcus garvieae strains from dairy environments. J Appl Microbiol 2007, 103:445-453.
39. Abiru Y., Ueno T., Uchiyama S. Isolation and characterization of novel S-equol-producing bacteria from brines of stinky tofu, a traditional fermented soy food in Taiwan. Int J Food Sci Nutr 2013, 64:936-943.
40. Yokoyama S., Suzuki T. Isolation and characterization of a novel equol-producing bacterium from human feces. Biosci Biotechnol Biochem 2008, 72:2660-2666.
41. Yokoyama S., Oshima K., Nomura I., Hattori M., Suzuki T. Complete genomic sequence of the equol-producing bacterium Eggerthella sp. strain YY7918, isolated from adult human intestine. J Bacteriol 2011, 193:5570-5571.
42. Schroder C., Matthies A., Engst W., Blaut M., Braune A. Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol 2013, 79(11):3494-3502.
43. Fujioka M., Uehara M., Wu J., Adlercreutz H., Suzuki K., Kanazawa K., et al. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr 2004, 134:2623-2627.
44. Kurahashi N., Iwasaki M., Inoue M., Sasazuki S., Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. J Clin Oncol 2008, 26:5923-5929.
45. Lampe J.W. Is equol the key to the efficacy of soy foodsα. Am J Clin Nutr 2009, 89:1664S-1667S.
46. Magee P.J. Is equol production beneficial to healthα. Proc Nutr Soc 2011, 70:10-18.
47. Setchell K.D., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132:3577-3584.
48. Wu J., Oka J., Ezaki J., Ohtomo T., Ueno T., Uchiyama S., et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause 2007, 14:866-874.
49. Duncan A.M., Merz-Demlow B.E., Xu X., Phipps W.R., Kurzer M.S. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000, 9:581-586.
50. Ursin G., London S., Stanczyk F.Z., Gentzschein E., Paganini-Hill A., Ross R.K., et al. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999, 91:1067-1072.
51. Atkinson C., Skor H.E., Dawn F.E., Scholes D., Chen C., Wahala K., et al. Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women. J Steroid Biochem Mol Biol 2003, 86:71-77.
52. Falk R.T., Fears T.R., Xu X., Hoover R.N., Pike M.C., Wu A.H., et al. Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev 2005, 14:221-226.
53. NutritionQuest Food Frequency Questionnaires for adults. Block Questionnaire-2005 FFQ 2013, [Internet: http://www.nutritionquest.com/assessment/list-of-questionnaires-and-screeners].
54. Pillow P.C., Duphorne C.M., Chang S., Contois J.H., Strom S.S., Spitz M.R., et al. Development of a database for assessing dietary phytoestrogen intake. Nutr Cancer 1999, 33:3-19.
55. Reinli K., Block G. Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 1996, 26:123-148.
56. Barnes S., Kirk M., Coward L. Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 1994, 42:2466-2474.
57. Prasain J.K., Arabshahi A., Moore D.R., Greendale G.A., Wyss J.M., Barnes S. Simultaneous determination of 11 phytoestrogens in human serum using a 2min liquid chromatography/tandem mass spectrometry method. J Chromatogr B Analyt Technol Biomed Life Sci 2010, 878:994-1002.
58. Setchell K.D., Cole S.J. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006, 136:2188-2193.
59. Cassidy A., Brown J.E., Hawdon A., Faughnan M.S., King L.J., Millward J., et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 2006, 136:45-51.
60. Fuhrman B.J., Teter B.E., Barba M., Byrne C., Cavalleri A., Grant B.J., et al. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:33-42.
61. Frankenfeld C.L., McTiernan A., Aiello E.J., Thomas W.K., LaCroix K., Schramm J., et al. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004, 13:1156-1162.
62. Hedlund T.E., Maroni P.D., Ferucci P.G., Dayton R., Barnes S., Jones K., et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr 2005, 135:1400-1406.
63. Verheus M., van Gils C.H., Keinan-Boker L., Grace P.B., Bingham S.A., Peeters P.H. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007, 25(6):648-655.
64. Ward H., Chapelais G., Kuhnle G.G., Luben R., Khaw K.T., Bingham S. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res 2008, 10:R32.
65. Frankenfeld C.L., Atkinson C., Thomas W.K., Gonzalez A., Jokela T., Wahala K., et al. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3years apart. Br J Nutr 2005, 94:873-876.
66. Franke A.A., Lai J.F., Halm B.M., Pagano I., Kono N., Mack W.J., et al. Equol production changes over time in postmenopausal women. J Nutr Biochem 2012, 23:573-579.
67. Franke A.A., Lai J.F., Pagano I., Morimoto Y., Maskarinec G. Equol production changes over time in pre-menopausal women. Br J Nutr 2012, 107:1201-1206.
68. Atkinson C., Newton K.M., iello Bowles E.J., Lehman C.D., Stanczyk F.Z., Westerlind K.C., et al. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. Breast Cancer Res Treat 2009, 116:587-594.